著者: CentonzeD, FurlanR, GasperiniC, SalvettiM, BattistiniL

原題: Early relapses after the first dose of natalizumab in active multiple sclerosis patients.

著者: AliRehiana, NicholasRichard St John, MuraroPaolo Antonio

原題: Drugs in development for relapsing multiple sclerosis.

著者: DerwenskusJoy

原題: Current disease-modifying treatment of multiple sclerosis.

著者: EagleTessa, StuartFiona, ChuaAlicia S, LaRussaAllison, LeclaireKaitlynne, CookSandra L, ChitnisTanuja, WeinerHoward L, GlanzBonnie I, HealyBrian C

原題: Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis.

著者: GotoAkira, ArimuraYoshiaki, ShinomuraYasuhisa, ImaiKohzoh, HinodaYuji

原題: Antisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis.

著者: AndersenJohanna Balslev, SellebjergFinn, MagyariMelinda

原題: Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis.

著者: FurneriGianluca, SantoniLaura, RicellaChiara, ProsperiniLuca

原題: Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy.

著者: MosesHarold, BrandesDavid W

原題: Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis.

著者:

原題: Natalizumab (Tysabri) for relapsing multiple sclerosis.

著者: CheraqpourKasra, AhmadrajiAliasghar, RashidiniaAli, IrannejadMaziyar, ShahriariMansoor

原題: Acute retinal necrosis caused by co-infection with multiple viruses in a natalizumab-treated patient: a case report and brief review of literature.

著者: SheremataW A, VollmerT L, StoneL A, Willmer-HulmeA J, KollerM

原題: A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.

著者: PortaccioEmilio, AnnovazziPietro, GhezziAngelo, ZaffaroniMauro, MoiolaLucia, MartinelliVittorio, LanzilloRoberta, Brescia MorraVincenzo, RinaldiFrancesca, GalloPaolo, TortorellaCarla, PaolicelliDamiano, PozzilliCarlo, De GiglioLaura, CavallaPaola, CoccoEleonora, MarrosuMaria Giovanna, PattiFrancesco, SolaroClaudio, BellantonioPaolo, UccelliAntonio, LaroniAlice, PastòLuisa, GianniniMarta, TrojanoMaria, ComiGiancarlo, AmatoMaria Pia,

原題: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

著者: GiannettiPaolo, NiccoliniFlavia, NicholasRichard

原題: BG-12 and its potential for the prevention of relapse in multiple sclerosis.

著者: ChawlaRohan, NathMadhu, MokshaLaxmi, NagTapas C, VelpandianThirumurthy

原題: An experimental study to evaluate safety/toxicity of intravitreal natalizumab.

著者: ComiGiancarlo, HartungHans-Peter, BakshiRajesh, WilliamsIan M, WiendlHeinz

原題: Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis.

著者: SatyanarayanSammita, SafiNeha, SoretsTali, FilomenaSusan, ZhangYinan, KlineovaSylvia, FabianMichelle, HorngSam, TankouStephanie, MillerAaron, KriegerStephen, LublinFred, SumowskiJames, Katz SandIlana

原題: Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis.

著者: AkataniRitsu, ChiharaNorio, KatanazakaKimitaka, UedaTakehiro, SekiguchiKenji, MatsumotoRiki

原題: [Increased disease activity in a case of multiple sclerosis after switching treatment from fingolimod to natalizumab].

著者: RudickR A, PaceA, RaniM R S, HydeR, PanzaraM, AppachiS, ShrockJ, MaurerS L, CalabresiP A, ConfavreuxC, GalettaS L, LublinF D, RadueE-W, RansohoffR M

原題: Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.

著者: PortaccioEmilio, MoiolaLucia, MartinelliVittorio, AnnovazziPietro, GhezziAngelo, ZaffaroniMauro, LanzilloRoberta, Brescia MorraVincenzo, RinaldiFrancesca, GalloPaolo, TortorellaCarla, PaolicelliDamiano, PozzilliCarlo, De GiglioLaura, CavallaPaola, CoccoEleonora, MarrosuMaria Giovanna, SolaroClaudio, UccelliAntonio, LaroniAlice, PastòLuisa, GianniniMarta, TrojanoMaria, ComiGiancarlo, AmatoMaria Pia,

原題: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

著者: BravoBeatriz, GallegoMarta I, FloresAna I, BornsteinRafael, Puente-BediaAlba, HernándezJavier, de la TorrePaz, García-ZaragozaElena, Perez-TavarezRaquel, GrandeJesús, BallesterAlicia, BallesterSara

原題: Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.

著者: RyersonLana Zhovtis, NaismithRobert T, KruppLauren B, CharvetLeigh E, LiaoShirley, FisherElizabeth, de MoorCarl, WilliamsJames R, CampbellNolan

原題: No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS.

著者: JefferyDouglas R

原題: Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.

著者: ChenJing, TaylorBruce V, BlizzardLeigh, SimpsonSteve, PalmerAndrew J, van der MeiIngrid A F

原題: Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data.

著者: MatsushitaTakuya

原題: [Multiple sclerosis: current therapies and future perspectives].

著者: HaanstraKrista G, HofmanSam O, Lopes EstêvãoDave M, BlezerErwin L A, BauerJan, YangLi-Li, WyantTim, CsizmadiaVilmos, 't HartBert A, FedykEric R

原題: Antagonizing the α4β1 integrin, but not α4β7, inhibits leukocytic infiltration of the central nervous system in rhesus monkey experimental autoimmune encephalomyelitis.